Compare · DHR vs QSI
DHR vs QSI
Side-by-side comparison of Danaher Corporation (DHR) and Quantum-Si Incorporated (QSI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and QSI operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $162.74B, about 567.6x QSI ($286.7M).
- Over the past year, DHR is up 9.5% and QSI is down 50.9% - DHR leads by 60.4 points.
- Both names hit the wire about 12 times in the past 4 weeks.
- DHR has more recent analyst coverage (25 ratings vs 4 for QSI).
- Company
- Danaher Corporation
- Quantum-Si Incorporated
- Price
- $229.01-1.05%
- $1.11-14.56%
- Market cap
- $162.74B
- $286.7M
- 1M return
- +7.76%
- +43.70%
- 1Y return
- +9.51%
- -50.88%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 12
- 12
- Recent ratings
- 25
- 4
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Quantum-Si Incorporated
Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.
Latest DHR
- SEC Form 3 filed by Danaher Corporation
- SEC Form 3 filed by Danaher Corporation
- SEC Form 4 filed by Danaher Corporation
- SEC Form 4 filed by Danaher Corporation
- Danaher Collaborates with NVIDIA to Advance Autonomous Science
- SEC Form 8-K filed by Danaher Corporation
- Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors
- Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab
- New insider Moler Heathre T claimed ownership of 5,356 shares (SEC Form 3)
- New insider Muppaneni Shashanka claimed ownership of 5,901 shares (SEC Form 3)
Latest QSI
- Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
- SEC Form 8-K filed by Quantum-Si Incorporated
- Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
- SEC Form 8-K filed by Quantum-Si Incorporated
- Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
- Quantum-Si Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
- President & CEO Hawkins Jeffrey Alan sold $22,611 worth of shares (29,852 units at $0.76), decreasing direct ownership by 0.81% to 3,639,950 units (SEC Form 4) to satisfy withholding tax
- Chief Financial Officer Keyes Jeffry R. sold $5,806 worth of shares (7,665 units at $0.76), decreasing direct ownership by 0.44% to 1,716,684 units (SEC Form 4) (for tax liability)
- GC & Corp. Secretary Lapointe Christian sold $10,995 worth of shares (14,516 units at $0.76), decreasing direct ownership by 1% to 1,167,913 units (SEC Form 4) to satisfy tax liability